Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Clinical trial NCT04531046 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04531046
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2022-04-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.